It has been shown to induce apoptosis in breast- and lung- cancer cells by downregulating the TGF-β/ERK signaling pathway and reversing the EMT process in breast cancer by inhibiting the HIF-1α pathway [54,55,56]. Here, TGFB1 is linked to lung carcinoma.